Botswana‑Harvard HIV Clinical Trials Partnership
Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU
This program runs clinical trials in Botswana to test new HIV treatments, prevention methods, and tuberculosis care for adults, children, and pregnant women.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Botswana Harvard Health Partnership NIH-funded |
| Lab location | 1 site (Gaborone, Botswana) |
| Project ID | NIH-11412843 on NIH RePORTER |
What this research studies
If you live in or near Gaborone or Molepolole, this partnership offers trials that test HIV medicines and prevention tools for adults, children, and pregnant women. The Clinical Trials Unit works with three international research networks to run studies on durable HIV treatments, strategies to reduce or stop daily antiretroviral therapy, and better care for HIV‑related infections like tuberculosis. Trials take place at clinics in both an urban center and a large village so people from different communities can join. Eligible participants receive care from experienced teams, regular monitoring, and may be asked to provide blood or other samples during follow‑up.
Who could benefit from this research
Good fit: Ideal participants are adults and children living with HIV in Botswana, including pregnant women, and people being treated for or at risk of tuberculosis.
Not a fit: People without HIV, those who live far from the trial sites, or those who do not meet specific health or age criteria would likely not be eligible or directly benefit.
Why it matters
Potential benefit: If successful, the work could bring safer, longer‑lasting HIV treatments, strategies to reduce or stop daily antiretroviral therapy, and improved prevention and treatment for tuberculosis and related infections.
How similar studies have performed: Previous HIV and TB clinical trials have produced many effective treatments and prevention tools, though approaches aiming for ART‑free remission remain experimental.
Where this research is happening
Gaborone, Botswana
- The Botswana Harvard Health Partnership — Gaborone, Botswana (Active)
Researchers
- Principal investigator: Makhema, Joseph Moeketsi — The Botswana Harvard Health Partnership
- Study coordinator: Makhema, Joseph Moeketsi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.